BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 37 filers reported holding BELLEROPHON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,594 | -48.1% | 180,066 | -10.0% | 0.00% | – |
| Q2 2023 | $138,052 | -91.3% | 200,075 | +0.0% | 0.00% | – |
| Q1 2023 | $1,578,521 | +818.0% | 200,066 | +4.7% | 0.00% | – |
| Q4 2022 | $171,959 | -21.1% | 191,065 | -4.5% | 0.00% | – |
| Q3 2022 | $218,000 | -11.4% | 200,063 | +0.0% | 0.00% | – |
| Q2 2022 | $246,000 | -47.9% | 200,057 | +0.0% | 0.00% | – |
| Q1 2022 | $472,000 | -23.9% | 200,052 | 0.0% | 0.00% | – |
| Q4 2021 | $620,000 | -38.9% | 200,052 | -20.0% | 0.00% | – |
| Q3 2021 | $1,015,000 | -16.2% | 250,052 | -0.1% | 0.00% | – |
| Q2 2021 | $1,211,000 | -7.2% | 250,256 | -0.5% | 0.00% | – |
| Q1 2021 | $1,305,000 | -3.3% | 251,416 | +24.3% | 0.00% | – |
| Q4 2020 | $1,350,000 | +20.3% | 202,330 | +83.5% | 0.00% | – |
| Q3 2020 | $1,122,000 | +5000.0% | 110,236 | +6163.4% | 0.00% | – |
| Q2 2020 | $22,000 | – | 1,760 | +11633.3% | 0.00% | – |
| Q1 2020 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFS Partners, LLC | 6,000 | $2,386 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 383,178 | $152 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 113,911 | $45,291 | 0.00% |
| OSAIC HOLDINGS, INC. | 557 | $221 | 0.00% |
| US BANCORP \DE\ | 1,221 | $485 | 0.00% |
| WELLS FARGO & COMPANY/MN | 180,066 | $71,594 | 0.00% |
| NORTHERN TRUST CORP | 30,251 | $12,028 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,100 | $840 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 95,656 | $38,262 | 0.00% |